Recent advances in epigenetic anticancer therapeutics and future perspectives

por Ren, Liwen, Yang, Yihui, Li, Wan, Yang, Hong, Zhang, Yizhi, Ge, Binbin, Zhang, Sen, Du, Guanhua, Wang, Jinhua
Publicado 2023

Suppression of CD13 Enhances the Cytotoxic Effect of Chemotherapeutic Drugs in Hepatocellular Carcinoma Cells

por Ji, Shengping, Ma, Yuqian, Xing, Xiaoyan, Ge, Binbin, Li, Yutian, Xu, Xinyue, Song, Jiliang, Xiao, Mei, Gao, Feng, Jiang, Wenyan, Fang, Chunyan, Wang, Xuejian
Publicado 2021

Progress on diagnostic and prognostic markers of pancreatic cancer

por YANG, HONG, LI, WAN, REN, LIWEN, YANG, YIHUI, ZHANG, YIZHI, GE, BINBIN, LI, SHA, ZHENG, XIANGJIN, LIU, JINYI, ZHANG, SEN, DU, GUANHUA, TANG, BO, WANG, HONGQUAN, WANG, JINHUA
Publicado 2023

CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis

por Ren, Liwen, Yang, Yihui, Li, Wan, Zheng, Xiangjin, Liu, Jinyi, Li, Sha, Yang, Hong, Zhang, Yizhi, Ge, Binbin, Zhang, Sen, Fu, Weiqi, Dong, Dexin, Du, Guanhua, Wang, Jinhua
Publicado 2022